Transchem Limited

As of June 30, 2026, Transchem Limited carries a market capitalization of 4.19B, placing it among publicly traded companies globally. Its enterprise value stands at 4.19B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Transchem Limited has 12.24M shares outstanding.

As of June 30, 2026, Transchem Limited trades at a trailing price-to-earnings ratio of 59.65.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately - - in revenue per employee across its workforce of 11.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Transchem Limited recorded 19.92M in income tax expense. That works out to an effective tax rate of 22.06, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 90.29M, leaving 70.37M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Transchem Limited's stock has gained approximately 507.94% over the past 52 weeks. The 50-day moving average sits at 378.27, while the 200-day moving average is 260.31.

Over the twelve months ended June 30, 2026, Transchem Limited generated - - in revenue and converted that into 70.37M in net income, yielding earnings per share of 5.74. EBITDA reached -36.01M, while operating income came in at -36.61M.